AANEM Practice News Express

AANEM News Express

Diagnostic Value of Sonography in Treatment-naïve Chronic Inflammatory Neuropathies

    5/17/2017
Physicians often need to distinguish inflammatory neuropathies from other neuropathies and motor neuron disorders. This study in Neurology discusses the use of ultrasound for diagnosis, and underlines that testing has robust merit.

CMS Lookup Tool—Determine Your MIPS Participation Status

    5/16/2017
The Center for Medicare and Medicaid Services (CMS) has released a new lookup tool that can help clinicians determine their Merit-Based Incentive System (MIPS) participation status. You should have also received a letter (or should in the next week or so) indicating whether or not you are eligible to participate in MIPS. 

Two Studies on Spinal Muscular Atrophy and Nusinersen

    5/3/2017
SMA is the most common genetic cause of infant death. In December 2016, Nusinersen, became the first approved drug to treat SMA while several other compounds remain in clinical trials. These studies in Neuron and the Lancet demonstrate potential effectiveness.

AANEM Succeeds in Changing BCBS-MA’s Medical Policy

    5/3/2017
In response to a request from AANEM, BlueCross BlueShield of Massachusetts (BCBS-MA) announced a revised policy to incorporate symptom-based ICD-10 diagnosis codes.

Efficacy and Safety of Deflazacort vs Prednisone and Placebo for Duchenne Muscular Dystrophy

    4/19/2017
Deflazacort, although already widely used in other countries, was recently approved by the FDA specifically for the treatment of boys with Duchene Muscular Dystrophy. While this study in Neurology does demonstrate better efficacy and lower side effects of deflazacort vs prednisone, the data is 20 years old.

CMS Releases Comparative Billing Reports on Sudomotor-Function Testing

    4/19/2017
In March, the Centers for Medicare & Medicaid Services (CMS) issued a national provider Comparative Billing Report (CBR) on Sudomotor-Function Testing. The CBR, produced by CMS contractor eGlobalTech and its partner, Palmetto GBA, will focus on providers that refer patients for sudomotor-function testing (using CPT Code 95923).

Clinical and Radiographic Findings in Patients with the C9orf72 Repeat Expansion and ALS

    4/5/2017
Two studies in JAMA Neurology and Journal of Neurology, Neurosurgery, and Psychiatry not only describe a new phenotypic model for ALS, but they also provide new imaging modalities for ALS subtyping, linking brain MRI findings with genetic or clinical manifestations.

Register for AMA MACRA/QPP webinar

    4/5/2017
The American Medical Association (AMA) is hosting a MACRA/QPP webinar on Thursday, April 20, 2017, at 7 PM EDT. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), represents the most significant change in Medicare physician payment policy in over 25 years. Last fall, the Centers for Medicare & Medicaid Services (CMS) released final policies on implementation of MACRA’s Merit-Based Incentive Payment System (MIPS) and alternative payment models (APMs). Collectively, these programs are part of what CMS now calls the Quality Payment Program (QPP).

Join the AMA for a MACRA/QPP Webinar on April 20

    4/5/2017
The American Medical Association (AMA) is hosting a MACRA/QPP webinar on Thursday, April 20, 2017 at 7 PM EDT. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), represents the most significant change in Medicare physician payment policy in over 25 years. Last fall, the Centers for Medicare & Medicaid Services (CMS) released final policies on implementation of MACRA’s Merit-Based Incentive Payment System (MIPS) and alternative payment models (APMs). Collectively, these programs are part of what CMS now calls the Quality Payment Program (QPP).

2017 Coding Guide Now Available

    3/22/2017
The AANEM 2017 Online Coding Guide is the most comprehensive source for electrodiagnostic (EDX) and neuromuscular (NM) coding.


First
Prev
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
...
Next
Last

Advertisement

ABEM

Advertisement

Donate

Advertisement